Investor Presentaiton

ASX Announcement 15 November 2021 AUSTRALIAN Clinicalabs Australian Clinical Labs Limited ABN 94 645 711 128 Registered Office: 1868-1892 Dandenong Road Clayton VIC 3168 Australia clinicallabs.com.au ACQUISITION OF MEDLAB PATHOLOGY - INVESTOR PRESENTATION Australian Clinical Labs (ACL or Company) provides to the market a copy of an investor presentation in respect of its binding agreement to acquire Medlab Pathology (Medlab), a leading Australian private pathology provider, with two laboratories and 288 collection centres across NSW and QLD. ACL Chief Executive Officer and Executive Director, Melinda McGrath, and Chief Financial Officer, James Davison, will host a webcast for investors and analysts today at 11.00am (Melbourne time). Participants can register for the webcast by accessing this link: https://us02web.zoom.us/webinar/register/WN plVy9STQS06H v6sR6uecw An archive of the briefing will be available afterwards at: https://investors.clinicallabs.com.au/ - ENDS - This announcement was authorised for release to ASX by the Board of Directors of ACL. For further information regarding this announcement, please contact: Investors Davina Gunn Media Sue Cato Media Relations Email: [email protected] Phone: +61 (0) 2 8306 4244 Investor Relations Email: [email protected] Phone: +61 (0) 400 896 809 About Australian Clinical Labs ACL is a leading Australian private provider of pathology services. Our 86 NATA accredited laboratories perform a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients. ACL is one of the largest private hospital pathology businesses nationally. ACL is focused on its mission of combining talented people, and medical and scientific leadership, with innovative thinking and technologies to empower decision making that saves and improves patients' lives. Forward looking-statements This announcement may contain forward-looking statements which are statements that may be identified by words such as "may", “will”, “would”, “should”, “could”, “believes", "estimates", "expects", "intends", "plans", "anticipates", "predicts", "outlook", "forecasts", "guidance" and other similar words that involve risks and uncertainties. These statements are based on an assessment of present economic and operating conditions and on a number of best estimate assumptions regarding future events and actions that, at the date of this announcement, are expected to take place. No person who has made any forward-looking statements in this announcement (including the Company) has any intention to update or revise forward-looking statements, or to publish prospective financial Page 1 of 2 Australian Clinical Labs Limited ABN 94 645 711 128

View entire presentation